Andrew S. Davis - May 20, 2024 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
May 20, 2024
Transactions value $
$12,318
Form type
4
Date filed
7/8/2024, 04:54 PM
Previous filing
Mar 5, 2024
Next filing
Sep 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $14.1K +2K +0.69% $7.05 290K May 20, 2024 Direct F1
transaction SILK Common Stock Sale -$1.78K -66 -0.02% $27.00 290K Jul 3, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F2 Represents shares that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.